In recent years, the healthcare landscape has witnessed a profound shift as plant-based medicines, including cannabis, have emerged as contenders to traditional pharmaceuticals.

Plant medicine refers to the use of natural substances derived from plants and herbs for therapeutic and medicinal purposes, often encompassing traditional and holistic healing practices.

These natural remedies, derived from various plants and herbs, are increasingly gaining market share in the wellness and healthcare industry. In the changed post-COVID-19 business landscape, the global market for herbal medicines, estimated at $135.8 billion in 2022, is projected to reach $248.6 billion by 2030, growing at a CAGR of 7.9%.

Plant-Based Medicines And The Cannabis Industry

As the plant medicine industry continues to grow, it is crucial for investors, entrepreneurs and healthcare professionals to stay informed about this transformative sector. That's where the Benzinga Cannabis Capital Conference

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.